Results 161 to 170 of about 11,680 (225)
Secondary neoplasms in mycosis fungoides: evaluating risk factors and phototherapy impact in a comparative study. [PDF]
Ann HematolAcar A +6 more
europepmc +1 more source
Phototherapy with Topical Minoxidil in Vitiligo: A Randomized Control Trial. [PDF]
Indian Dermatol Online JBajoria S +6 more
europepmc +1 more source
Management Strategies for Generalised Granuloma Annulare: A Systematic Review of Current and Emerging Therapies. [PDF]
Australas J DermatolBettolini L +11 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Dermatologic Clinics, 1995
The goal of photochemotherapy in psoriasis is to attempt to lower the number of exposures and the total cumulative doses while still maintaining good control of the disease. PUVA has been modified by using better psoralen preparations and more effective light sources, and it also has been combined with other treatment modalities.
K, Momtaz-T, T B, Fitzpatrick
openaire +2 more sources
The goal of photochemotherapy in psoriasis is to attempt to lower the number of exposures and the total cumulative doses while still maintaining good control of the disease. PUVA has been modified by using better psoralen preparations and more effective light sources, and it also has been combined with other treatment modalities.
K, Momtaz-T, T B, Fitzpatrick
openaire +2 more sources
Dermatologic Clinics, 1995
The development in 1974 of psoralen photochemotherapy (PUVA) for severe psoriasis transformed the therapeutic setting for this disease from in-patient to ambulatory, presaging the trend in the past decade to reduce hospitalization. The prospective evaluation of this treatment in well-designed, well-controlled studies with the participation of a large ...
openaire +2 more sources
The development in 1974 of psoralen photochemotherapy (PUVA) for severe psoriasis transformed the therapeutic setting for this disease from in-patient to ambulatory, presaging the trend in the past decade to reduce hospitalization. The prospective evaluation of this treatment in well-designed, well-controlled studies with the participation of a large ...
openaire +2 more sources
PUVA-induced melanocytic atypia: Is it confined to PUVA lentigines?
Journal of the American Academy of Dermatology, 1985Widespread lentigines in fourteen patients following long-term therapy with psoralens and ultraviolet A (PUVA) for psoriasis were documented by biopsy of a representative lesion in a non-sun-exposed site. Chronically PUVA-exposed nonlesional skin was examined in ten of the fourteen patients.
E A, Abel, H, Reid, C, Wood, C H, Hu
openaire +2 more sources
Cryotherapy of PUVA lentigines
British Journal of Dermatology, 1996PUVA lentigines do not subside after discontinuation of photochemotherapy. Cryotherapy with liquid nitrogen was done on a small area in a patient who presented with numerous PUVA lentigines. Five years after this treatment, the PUVA lentigines had not returned. Cosmetically disturbing PUVA lentigines can be treated with cryotherapy.
D, Leroy +3 more
openaire +2 more sources
The Journal of Dermatology, 2003
AbstractA 28‐year‐old male with histologically proven psoriasis vulgaris was administered oral 8‐methoxypsoralen UVA therapy (PUVA). The plaques of psoriasis gradually responded to treatment, however numerous pruritic, violaceous papules over the right forearm and left thigh developed 5 months after starting PUVA (45 sittings with a cumulative dose of ...
Soni, Nanda +2 more
openaire +2 more sources
AbstractA 28‐year‐old male with histologically proven psoriasis vulgaris was administered oral 8‐methoxypsoralen UVA therapy (PUVA). The plaques of psoriasis gradually responded to treatment, however numerous pruritic, violaceous papules over the right forearm and left thigh developed 5 months after starting PUVA (45 sittings with a cumulative dose of ...
Soni, Nanda +2 more
openaire +2 more sources